Evaluation of p75 expression and patterns of recurrence in patients with malignant gliomas treated with bevacizumab.

被引:0
|
作者
Urgoiti, Gloria Roldan
Lawn, Sam
Scott, James
Easaw, Jacob C.
Kenchappa, Rajappa
Taylor, Jennie Webster
Paleologos, Nina
Schiff, David
Chan, Jennifer
Forsyth, Peter A. J.
机构
[1] Univ Calgary, Fac Med, Dept Oncol, Tom Baker Canc Ctr, Calgary, AB, Canada
[2] Univ Calgary, Fac Med, Diagnost Imaging & Clin Neurosci, Calgary, AB, Canada
[3] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA
[4] UC San Francisco, San Francisco, CA USA
[5] Northshore Univ HealthSyst, Evanston, IL USA
[6] Univ Virginia, Med Ctr, Charlottesville, VA USA
[7] Univ Calgary, Dept Pathol & Lab Med, Calgary, AB, Canada
[8] Univ Calgary, Dept Clin Neurosci, Calgary, AB, Canada
[9] Univ Calgary, Dept Oncol, Calgary, AB, Canada
[10] Univ S Florida, H Lee Moffitt Canc Ctr, Tampa, FL 33682 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e13006
引用
收藏
页数:1
相关论文
共 50 条
  • [1] RADIOGRAPHIC PATTERNS OF RECURRENCE WITH PATHOLOGIC CORRELATION IN PATIENTS WITH MALIGNANT GLIOMAS TREATED WITH BEVACIZUMAB (BEV)
    Kaley, Thomas J.
    Huse, Jason
    Karimi, Sasan
    Rosenblum, Marc
    Omuro, Antonio
    DeAngelis, Lisa M.
    [J]. NEURO-ONCOLOGY, 2011, 13 : 2 - 2
  • [2] The infiltrative, diffuse pattern of recurrence in patients with malignant gliomas treated with bevacizumab
    Potthast, L.
    Chowdhary, S.
    Pan, E.
    Yu, D.
    Zhu, W.
    Brem, S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [3] Neurotrophin receptor p75 regulates the invasiveness of malignant gliomas
    [J]. Nature Clinical Practice Neurology, 2007, 3 (11): : 597 - 597
  • [4] Bevacizumab for recurrent malignant gliomas - Efficacy, toxicity, and patterns of recurrence
    Norden, A. D.
    Young, G. S.
    Setayesh, K.
    Muzikansky, A.
    Klufas, R.
    Ross, G. L.
    Ciampa, A. S.
    Ebbeling, L. G.
    Levy, B.
    Drappatz, J.
    Kesari, S.
    Wen, P. Y.
    [J]. NEUROLOGY, 2008, 70 (10) : 779 - 787
  • [5] Retrospective study of bevacizumab for recurrent malignant gliomas and analysis of the patterns of recurrence
    Norden, Andrew D.
    Young, Geoffrey
    Setayesh, Kian
    Muzikansky, Alona
    Klufas, Roman
    Ross, Gina
    Drappatz, Jan
    Kesari, Santosh
    Ciampa, Abigail Slate
    Ebbeling, Laura G.
    Levy, Brenda
    Wen, Patrick
    [J]. NEURO-ONCOLOGY, 2007, 9 (04) : 515 - 516
  • [6] Bevacizumab and chemotherapy for recurrent malignant gliomas: Efficacy, toxicity, and recurrence patterns
    Norden, Andrew
    Young, Geoffrey S.
    Setayesh, Kian
    Muzikansky, Alona
    Klufas, Roman
    Ross, Gina L.
    Ciampa, Abigail S.
    Ebbeling, Laura G.
    Levy, Brenda
    Drappatz, Jan
    Kesari, Santosh
    Wen, Patrick
    [J]. NEUROLOGY, 2008, 70 (11) : A110 - A111
  • [7] OPTIC NEUROPATHY IN PATIENTS WITH MALIGNANT GLIOMAS TREATED WITH BEVACIZUMAB
    Sherman, Jonathan
    Aregawi, Dawit
    Lai, Albert
    Rosenfeld, Steven
    Fathallah-Shaykh, Hassan
    Larner, James
    Newman, Steven
    Schiff, David
    [J]. NEURO-ONCOLOGY, 2008, 10 (05) : 816 - 816
  • [8] OPTIC NEUROPATHY IN PATIENTS WITH MALIGNANT GLIOMAS TREATED WITH BEVACIZUMAB
    Sherman, J. H.
    Aregawi, D. G.
    Lai, A.
    Rosenfeld, S. S.
    Fathallah-Shaykh, H. M.
    Larner, J. M.
    Newman, S. A.
    Schiff, D.
    [J]. NEURO-ONCOLOGY, 2008, 10 (06) : 1076 - 1076
  • [9] BEVACIZUMAB FOR RECURRENT MALIGNANT GLIOMAS: EFFICACY, TOXICITY, AND PATTERNS OF RECURRENCE Reply from the Authors
    Norden, Andrew D.
    Young, Geoffrey S.
    Wen, Patrick Y.
    [J]. NEUROLOGY, 2009, 72 (08) : 773 - 774
  • [10] Relationship of the p75 neurotrophin receptor (p75NTR) and hypoxic response and treatment resistance in malignant gliomas.
    Kenchappa, Rajappa
    Forsyth, Peter A. J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)